Financials Theraclion

Equities

ALTHE

FR0010120402

Advanced Medical Equipment & Technology

Market Closed - Euronext Paris 11:35:29 2024-04-26 am EDT 5-day change 1st Jan Change
0.36 EUR -1.10% Intraday chart for Theraclion +4.35% -7.22%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 30.6 5.637 24.67 30.8 29.81 26.15
Enterprise Value (EV) 1 31.86 10.85 29.91 39.07 36.8 32.67
P/E ratio -4.92 x -0.92 x -6.63 x -8.37 x -7.93 x -5.35 x
Yield - - - - - -
Capitalization / Revenue 10.8 x 2.91 x 7.88 x 41.4 x 20.1 x 21.2 x
EV / Revenue 11.3 x 5.6 x 9.55 x 52.5 x 24.8 x 26.4 x
EV / EBITDA -4.71 x -1.64 x -6.68 x -9.42 x -8.35 x -5.3 x
EV / FCF -5.71 x -4.07 x -10.5 x -12.2 x -13.7 x -6.8 x
FCF Yield -17.5% -24.6% -9.51% -8.17% -7.31% -14.7%
Price to Book 8.81 x -10.6 x -315 x -10.1 x -23.4 x 48.7 x
Nbr of stocks (in thousands) 7,482 8,413 14,949 15,249 22,757 28,925
Reference price 2 4.090 0.6700 1.650 2.020 1.310 0.9040
Announcement Date 4/27/18 4/4/19 4/30/20 4/29/22 4/29/22 4/29/23
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 2.824 1.939 3.13 0.744 1.481 1.235
EBITDA 1 -6.767 -6.637 -4.48 -4.15 -4.405 -6.163
EBIT 1 -7.098 -6.977 -4.708 -4.288 -4.535 -6.307
Operating Margin -251.32% -359.79% -150.4% -576.36% -306.22% -510.54%
Earnings before Tax (EBT) 1 -7.372 -7.323 -5.061 -4.628 -4.643 -5.966
Net income 1 -6.224 -6.144 -3.792 -3.905 -3.76 -4.964
Net margin -220.38% -316.84% -121.14% -524.9% -253.92% -401.83%
EPS 2 -0.8308 -0.7280 -0.2487 -0.2414 -0.1652 -0.1689
Free Cash Flow 1 -5.576 -2.67 -2.844 -3.193 -2.691 -4.805
FCF margin -197.42% -137.69% -90.87% -429.17% -181.69% -388.96%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/27/18 4/4/19 4/30/20 4/29/22 4/29/22 4/29/23
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 1.26 5.22 5.24 8.27 6.99 6.52
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -0.1858 x -0.7862 x -1.17 x -1.992 x -1.586 x -1.058 x
Free Cash Flow 1 -5.58 -2.67 -2.84 -3.19 -2.69 -4.81
ROE (net income / shareholders' equity) -138% -418% 1,240% 235% 167% 1,364%
ROA (Net income/ Total Assets) -31.2% -37.4% -29.3% -25.5% -25.3% -30.6%
Assets 1 19.98 16.44 12.94 15.34 14.84 16.23
Book Value Per Share 2 0.4600 -0.0600 -0.0100 -0.2000 -0.0600 0.0200
Cash Flow per Share 2 0.6500 0.1100 0.0900 0.1400 0.1100 0.0800
Capex 1 0.18 0.16 0.13 0.13 0.15 0.32
Capex / Sales 6.55% 8.43% 4.2% 17.73% 10.01% 26.12%
Announcement Date 4/27/18 4/4/19 4/30/20 4/29/22 4/29/22 4/29/23
1EUR in Million2EUR
Estimates